Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes | Nature Communications
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors | Science Translational Medicine
Targeted therapies in lung cancer and Biomarkers
Cancers | Free Full-Text | EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance
Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunities | British Journal of Cancer
Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop - ScienceDirect
Cancers | Free Full-Text | Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies
Gene Mutations in Lung Cancer: Promising Predictive Factors for the Success of Molecular Therapy | PLOS Medicine
Cetuximab-Triptolide Conjugate Suppresses the Growth of EGFR-Overexpressing Lung Cancers through Targeting RNA Polymerase II: Molecular Therapy - Oncolytics
Cancer Cytopathology on Twitter: "Data reveals cell-free DNA can be extracted from lung cancer FNA supernatants for EGFR mutation analysis, an important marker for targeted therapy in patients with advanced lung cancer.
EGFR | Cancer Genetics Web
Nanoscale Mapping of EGFR and c-MET Protein Environments on Lung Cancer Cell Surfaces via Therapeutic Antibody Photocatalyst Conjugates | ACS Chemical Biology
Figures and data in Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer | eLife
Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer | BMC Cancer | Full Text
Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports
Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity - ScienceDirect
Overcoming therapy resistance in EGFR-mutant lung cancer | Nature Cancer
Overexpression of BZW1 and EGFR is a strong poor prognosis marker for... | Download Scientific Diagram
The biology of EGFR mutations in lung cancer. In normal cells, binding... | Download Scientific Diagram
EGFR and Lung Cancer | American Lung Association
Lung cancer - The Lancet
Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a multicohort study - The Lancet Digital Health
Multiplicity of EGFR and KRAS Mutations in Non-small Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors | Anticancer Research
Molecular Markers and Targeted Therapies in the Management of Non-Small Cell Lung Cancer | MDedge Hematology and Oncology
Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis - eBioMedicine
A favourable prognostic marker for EGFR mutant non-small cell lung cancer: immunohistochemical analysis of MUC5B | BMJ Open
